SeaStar Medical Holding Corp has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of August 27, 2024, at 4:30 P.M. The filing, under the file number 333-280683, is a significant step for the company, indicating that it has met the necessary SEC requirements to issue securities under the Securities Act. This development could potentially pave the way for SeaStar Medical to raise capital through the sale of securities.

SeaStar Medical Holding Corp has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of August 27, 2024, at 4:30 P.M. The filing, under the file number 333-280683, is a significant step for the company, indicating that it has met the necessary SEC requirements to issue securities under the Securities Act. This development could potentially pave the way for SeaStar Medical to raise capital through the sale of securities.